Form D/A — Duo Oncology Inc.
0001843372-26-000004 · filed Jun 9, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $3,000,000
- Reported amount sold
- $1,425,000
- Minimum investment
- $25,000
- Investors
- 13
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Duo Oncology Inc.
- CIK
- 1843372
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 218 OAKLAND AVE
PITTSBURGH, PA 15213 - Phone
- 412-709-1659
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
SAM ROTHSTEIN · Executive OfficerPITTSBURGH, PA Find on LinkedIn ↗
-
JING-ZHOU HOU · Executive OfficerPITTSBURGH, PA Find on LinkedIn ↗
-
STEPHEN THORNE · Executive OfficerPITTSBURGH, PA Find on LinkedIn ↗
-
SONG LI · DirectorPITTSBURGH, PA Find on LinkedIn ↗
-
STANLEY MARKS · DirectorPITTSBURGH, PA Find on LinkedIn ↗
-
LUSONG LUO · DirectorPITTSBURGH, PA Find on LinkedIn ↗
-
JOE GATTO · DirectorPITTSBURGH, PA Find on LinkedIn ↗
-
VICTORIA MANAX · DirectorPITTSBURGH, PA Find on LinkedIn ↗
-
KATHERINE EICHINGER · Executive OfficerPITTSBURGH, PA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗